Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 5 3 2019
medline: 23 6 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

In the United Kingdom, liver transplantation (LT) is undertaken in 7 supraregional centers. Until March 2018, liver grafts were offered to a center and allocated to a patient on their elective waiting list (WL) based on unit prioritization. Patients in Newcastle, Leeds, and Edinburgh with a United Kingdom Model for End-Stage Liver Disease (UKELD) score ≥62 were registered on a common WL and prioritized for deceased-donor liver allocation. This was known as the Northern Liver Alliance (NLA) "top-band scheme." Organs were shared between the 3 centers, with a "payback" scheme ensuring no patient in any center was disadvantaged. We investigated whether the NLA had improved WL survival and waiting time (WT) to transplantation. Data for this study were obtained from the UK Transplant Registry maintained by National Health Service Blood and Transplant. This study was based on adult patients registered for first elective liver transplant between April 2013 and December 2016. Non-NLA centers were controls. The Kaplan-Meier method was used to estimate WL survival and median WT to transplant, with the log-rank test used to make comparisons; a Bonferroni correction was applied post hoc to determine pairwise differences. WT was significantly lower at NLA centers compared with non-NLA centers for top-band patients (23 versus 99 days, P < 0.001). However, WL survival was not significantly different for top-band patients (P > 0.999) comparing NLA with non-NLA centers. WL survival for nontop-band patients was no different (P > 0.999) comparing NLA with non-NLA centers. The NLA achieved its aim, providing earlier transplantation to patients with the greatest need. Nontop-band patients did not experience inferior survival.

Sections du résumé

BACKGROUND
In the United Kingdom, liver transplantation (LT) is undertaken in 7 supraregional centers. Until March 2018, liver grafts were offered to a center and allocated to a patient on their elective waiting list (WL) based on unit prioritization. Patients in Newcastle, Leeds, and Edinburgh with a United Kingdom Model for End-Stage Liver Disease (UKELD) score ≥62 were registered on a common WL and prioritized for deceased-donor liver allocation. This was known as the Northern Liver Alliance (NLA) "top-band scheme." Organs were shared between the 3 centers, with a "payback" scheme ensuring no patient in any center was disadvantaged. We investigated whether the NLA had improved WL survival and waiting time (WT) to transplantation.
METHODS
Data for this study were obtained from the UK Transplant Registry maintained by National Health Service Blood and Transplant. This study was based on adult patients registered for first elective liver transplant between April 2013 and December 2016. Non-NLA centers were controls. The Kaplan-Meier method was used to estimate WL survival and median WT to transplant, with the log-rank test used to make comparisons; a Bonferroni correction was applied post hoc to determine pairwise differences.
RESULTS
WT was significantly lower at NLA centers compared with non-NLA centers for top-band patients (23 versus 99 days, P < 0.001). However, WL survival was not significantly different for top-band patients (P > 0.999) comparing NLA with non-NLA centers. WL survival for nontop-band patients was no different (P > 0.999) comparing NLA with non-NLA centers.
CONCLUSIONS
The NLA achieved its aim, providing earlier transplantation to patients with the greatest need. Nontop-band patients did not experience inferior survival.

Identifiants

pubmed: 30830042
doi: 10.1097/TP.0000000000002687
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2304-2311

Auteurs

Abdullah K Malik (AK)

Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Steven Masson (S)

Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Elisa Allen (E)

Statistics and Clinical Studies, NHS Blood and Transplant, Stoke Gifford, Bristol, United Kingdom.

Murat Akyol (M)

Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Scotland, United Kingdom.

Andrew Bathgate (A)

Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Scotland, United Kingdom.

Mervyn Davies (M)

Leeds Transplant Unit, St James's University Hospital, Leeds, United Kingdom.

Ernest Hidalgo (E)

Leeds Transplant Unit, St James's University Hospital, Leeds, United Kingdom.

Mark Hudson (M)

Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

James Powell (J)

Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Scotland, United Kingdom.

Rhiannon Taylor (R)

Statistics and Clinical Studies, NHS Blood and Transplant, Stoke Gifford, Bristol, United Kingdom.

Agne Zarankaite (A)

Statistics and Clinical Studies, NHS Blood and Transplant, Stoke Gifford, Bristol, United Kingdom.

Derek M Manas (DM)

Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH